Prescribing Information & Guidance
Moderate to Severe Rheumatoid Arthritis – Drug treatment Options (Algorithm A)
Guideline added to website on: 02/12/21
Last modified on: 11/01/22
CCG: Bedfordshire | Luton
Section: Clinical Guidelines & Pathways | Prescribing Information & Guidance
Category: Rheumatology
Tags: Arthritis, rheumatoid
Updated Dec 2021 : - Algorithm A :- Changes made to drug choices for treating moderate disease ; Algorithm B: - Approved for use across BLMK ; Addition of tocilizumab supply disruption alert (applicable to both algorithms A & B)
For patients with the following co-morbidities: history of malignancy; previous melanoma; bronchiectasis; pulmonary fibrosis; multiple sclerosis; SLE; click here:
Tocilizumab supply disruption alert
Posted in Rheumatology
Tagged with: Arthritis | rheumatoid